nMed Partners, LP is a hedge fund based in Rye, New York. According to its most recent Form D, filed Feb 23, 2022, the fund has sold $2,100,000 of interests to 6 investors since its first sale in Jan 2020. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Robert Field.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $2,100,000Cumulative sales reported on Form D
- Investors
- 6
- First sale
- Jan 31, 2020
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Robert Field
- Latest Form D
- Feb 23, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about nMed Partners, LP
What is the minimum investment for nMed Partners, LP?
nMed Partners, LP's latest Form D, filed Feb 23, 2022, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in nMed Partners, LP?
nMed Partners, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has nMed Partners, LP raised?
nMed Partners, LP reports $2,100,000 sold from 6 investors on its Form D filed Feb 23, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is nMed Partners, LP based?
nMed Partners, LP is based in Rye, New York.
When did nMed Partners, LP launch?
nMed Partners, LP reports its first sale in Jan 2020.
Size compared with every hedge fund
Raised more than 14% of the 2,528 hedge funds based in New York, and more than 9% of all 10,139 that report sales.